Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03382561
Title Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung small cell carcinoma

Therapies

Cisplatin + Etoposide + Nivolumab

Carboplatin + Etoposide + Nivolumab

Cisplatin + Etoposide

Carboplatin + Etoposide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.